CVE-2022-1410

CVE-2022-1410 is a high-severity vulnerability in Device42 Cmdb with a CVSS 3.x base score of 8.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

OS Command Injection vulnerability in the db_optimize component of Device42 Asset Management Appliance allows an authenticated attacker to execute remote code on the device. This issue affects: Device42 CMDB version 18.01.00 and prior versions.

Frequently asked questions

What is CVE-2022-1410?
OS Command Injection vulnerability in the db_optimize component of Device42 Asset Management Appliance allows an authenticated attacker to execute remote code on the device. This issue affects: Device42 CMDB version 18.01.00 and prior versions.
How severe is CVE-2022-1410?
CVE-2022-1410 has a CVSS 3.x base score of 8.0, rated high severity. It is exploitable over an adjacent network with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-1410 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (59th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-1410?
CVE-2022-1410 affects Device42 Cmdb. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-1410?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-1410 published?
CVE-2022-1410 was published on 2022-08-17 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Device42 Cmdb

All CVEs affecting Device42 Cmdb →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →